Codexis Inc
Research Codexis Inc (CDXS) on Bullrun: market cap USD 153.53M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCDXS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 153.53M
- Financial periodQ1 2026
- RevenueUSD 78.09M
- Net income-USD 31.99M
- Free cash flow-USD 13.33M
- Gross margin16.9%
Valuation Snapshot
latest market cap is USD 153.53M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 70.39M | -USD 43.97M | -USD 23.85M | 86.7% | -0.5 | USD 50.79M | USD 40.11M | USD 50.53M |
| FY2024 | USD 59.35M | -USD 65.28M | -USD 53.72M | 72.6% | -0.89 | USD 19.26M | USD 28.91M | USD 66.93M |
| FY2023 | USD 70.14M | -USD 76.24M | -USD 57.06M | 81.7% | -1.12 | USD 65.12M | USD 0 | USD 86.62M |
| FY2022 | USD 138.59M | -USD 33.59M | USD 2.98M | 72.6% | -0.51 | USD 113.98M | USD 46.11M | USD 144.80M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 153.53M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 147.48M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 390.42M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 212.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 306.10M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.04B | n/a | n/a | n/a |
About Codexis Inc
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Codexis Inc's market cap?
Codexis Inc's market capitalization is USD 153.53M.
What does Codexis Inc do?
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc.